Key abstracts highlight advances in treating locally advanced and refractory disease
Important takeaways from a rare complication
Study examines how infiltrative features affect prognosis
Better assessing individual risk of recurrence
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Another option for immunotherapy
Single-center series reveals high perioperative, long-term complications in these complex procedures
Combo therapy shows longer OS and PFS and higher ORR
Identifying low and high risk of recurrence
But the combination increases toxicity risks
Clinical efficacy uncompromised in previously untreated patients